Logo-jrip

Indexing Information

Scupos

Member of

Follower of





 

J Renal Inj Prev. 2019;8(1): 54-61. doi: 10.15171/jrip.2019.11

Review

Metformin and its anti-inflammatory and anti-oxidative effects; new concepts

Ali Hasanpour Dehkordi 1, Abolfazl Abbaszadeh 2, Samareh Mir 3, Amin Hasanvand 4 *

Cited by CrossRef: 39

1- Jacob S, Knoll S, Huhn C, Köhler H, Tisler S, Zwiener C, Triebskorn R. Effects of guanylurea, the transformation product of the antidiabetic drug metformin, on the health of brown trout (Salmo trutta f. fario). 2019;7:e7289 [Crossref]
2- GÜMÜŞ E, ERGÜL M, GÜLMEZ K, ULU M, AKKAYA R, ÖZDEMİR E, TAŞKIRAN A. Protective Effect of Metformin Alone or in Combination with Valproic acid on Pentylenetetrazole-Induced Seizures in Mice. 2022;17(3):15 [Crossref]
3- An W, Kang J. Effect of Metformin on Myocardial Injury Induced by Hepatic Ischemia-Reperfusion in Rats. Front Pharmacol. 2022;13 [Crossref]
4- Poor S, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine P, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment. Pharmaceuticals. 2021;14(9):890 [Crossref]
5- García-Sánchez A, Miranda-Díaz A, Cardona-Muñoz E. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases. Oxidative Medicine and Cellular Longevity. 2020;2020:1 [Crossref]
6- Veselov I, Vinogradova D, Maltsev A, Shevtsov P, Spirkova E, Bachurin S, Shevtsova E. Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus. IJMS. 2023;24(19):14450 [Crossref]
7- Mostafa F, Abdel-Moneim A, Abdul-Hamid M, Galaly S, Mohamed H. RETRACTED ARTICLE: Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats. J Mol Histol. 2021;52(2):135 [Crossref]
8- Aryastuti S, Sintya E, Asri Lestarini A, Witari N. Allele Frequency of a Common Variants and Two Common Loss-of-Function Variants in Organic Cation Transporter 1 (OCT1) among Balinese Diabetic Patients. Biomed Pharmacol J. 2022;15(1):269 [Crossref]
9- Rahman M, Sarker M, Ahmed S, Uddin M, Islam M, Islam M, Das S, Mukherjee N, Hemeg H, Rauf A, Ghimire B, Thiruvengadam M. Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance. Process Biochemistry. 2023;132:41 [Crossref]
10- Karbalaee-Hasani A, Khadive T, Eskandari M, Shahidi S, Mosavi M, Nejadebrahimi Z, Khalkhali L, Sangdari A, Mohammadi D, Soltani A, Khodabandehloo H, Hosseini H, Koushki M. Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Pharmacother. 2021;55(9):1096 [Crossref]
11- Ramesh P, Balkrishna B, Kashinath A, Ramnath N. Co-Administration of Polyamines with Rutin and Metformin Ameliorates Streptozotocin-Induced Diabetes: Possible Involvement of Antioxidants, Inflammatory Cytokines, and Biochemical Paradigms. Rev Bras Farmacogn. 2023;34(2):370 [Crossref]
12- Daniali M, Baeeri M, Farhadi R, Gholami M, Hassani S, Navaei-Nigjeh M, Rahimifard M, Abdollahi M. Molecular Evidence on the Inhibitory Potential of Metformin against Chlorpyrifos-Induced Neurotoxicity. Toxics. 2022;10(4):197 [Crossref]
13- Moon J, Park J, Jeong J, Sung N, Jeong Y, Song K, Ahn J, Lee N, Han S. Metformin-loaded Citric Acid Cross-linked Agarose Films in the Prevention of Postoperative Abdominal Adhesion. Anat Biol Anthropol. 2019;32(4):129 [Crossref]
14- Bramante C, Buse J, Tamaritz L, Palacio A, Cohen K, Vojta D, Liebovitz D, Mitchell N, Nicklas J, Lingvay I, Clark J, Aronne L, Anderson E, Usher M, Demmer R, Melton G, Ingraham N, Tignanelli C. Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity. Journal of Medical Virology. 2021;93(7):4273 [Crossref]
15- Arabmoazzen S, Mirshekar M. Evaluation of the effects of metformin as adenosine monophosphate-activated protein kinase activator on spatial learning and memory in a rat model of multiple sclerosis disease. Biomedicine & Pharmacotherapy. 2021;141:111932 [Crossref]
16- Mansouri K, Rastegari-Pouyani M, Ghanbri-Movahed M, Safarzadeh M, Kiani S, Ghanbari-Movahed Z. Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational. Biomedicine & Pharmacotherapy. 2020;131:110694 [Crossref]
17- Logette E, Lorin C, Favreau C, Oshurko E, Coggan J, Casalegno F, Sy M, Monney C, Bertschy M, Delattre E, Fonta P, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann A, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health. 2021;9 [Crossref]
18- Za’abi M, Ali B, Al Suleimani Y, Adham S, Ali H, Manoj P, Ashique M, Nemmar A. The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease. Biomolecules. 2021;11(6):814 [Crossref]
19- Karam H, Lotfy D, M. Ibrahim A, Mosallam F, Abdelrahman S, Abd-ElRaouf A. A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway. Naunyn-Schmiedeberg's Arch Pharmacol. 2024; [Crossref]
20- Ibrahim S, Lowe J, Bramante C, Shah S, Klatt N, Sherwood N, Aronne L, Puskarich M, Tamariz L, Palacio A, Bomberg E, Usher M, King S, Benson B, Vojta D, Tignanelli C, Ingraham N. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. Front Endocrinol. 2021;12 [Crossref]
21- Abdel-Latif A, Abu-Risha S, Bakr S, EL-Kholy W, EL-Sawi M. Potassium bromate-induced nephrotoxicity and potential curative role of metformin loaded on gold nanoparticles. Science Progress. 2021;104(3):003685042110337 [Crossref]
22- Khodadadi M, Jafari-Gharabaghlou D, Zarghami N. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging. Pharmacol Rep. 2022;74(2):310 [Crossref]
23- Nuwormegbe S, Kim S. AMPK Activation by 5-Amino-4-Imidazole Carboxamide Riboside-1-β-D-Ribofuranoside Attenuates Alkali Injury-Induced Corneal Fibrosis. Invest Ophthalmol Vis Sci. 2020;61(6):43 [Crossref]
24- Hebert J, Myatt L. Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2021;1867(1):165967 [Crossref]
25- Zhang J, Li F, Nie D, Onishi K, Hogan M, Wang J. Effect of Metformin on Development of Tendinopathy Due to Mechanical Overloading in an Animal Model. Foot Ankle Int. 2020;41(12):1455 [Crossref]
26- Katila N, Bhurtel S, Park P, Choi D. Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT/Nrf2 pathway. Neurochemistry International. 2021;148:105120 [Crossref]
27- Ailuno G, Baldassari S, Balboni A, Pastorino S, Zuccari G, Cortese K, Barbieri F, Drava G, Florio T, Caviglioli G. Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases. Pharmaceutics. 2024;16(2):235 [Crossref]
28- Sari D, Ahmad F, Djabir Y, Yulianty R. Breadfruit leaves extract (Artocarpus altilis) effect on pancreatic damage in diabetic type II animal model induced by alloxan–nicotinamide. Medicina Clínica Práctica. 2020;3:100099 [Crossref]
29- Tony S, Hassan M, Ismail H, El-Naem G, Gazwi H. Effect of anthocyanin-rich blackberry juice on endoplasmic reticulum stress in streptozotocin-induced diabetic rats. Environ Sci Pollut Res. 2023;30(32):79067 [Crossref]
30- Johanns M, Hue L, Rider M. AMPK inhibits liver gluconeogenesis: fact or fiction?. 2023;480(1):105 [Crossref]
31- Bakry H, Mansour N, ElKhodary T, Soliman M. Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial. Front Pharmacol. 2023;14 [Crossref]
32- Augusto C, de la Paz Scribano Parada M, Rossi M, Signorini F, Fonseca I, del Carmen Baez M. Pharmacological Action of Atorvastatin and Metformin on Non-alcoholic Fatty Liver Disease on an Experimental Model of Metabolic Syndrome. AIAAMC. 2021;21(3):194 [Crossref]
33- Obafemi T, Jaiyesimi K, Olomola A, Olasehinde O, Olaoye O, Adewumi F, Afolabi B, Adewale O, Akintayo C, Ojo O. Combined effect of metformin and gallic acid on inflammation, antioxidant status, endoplasmic reticulum (ER) stress and glucose metabolism in fructose-fed streptozotocin-induced diabetic rats. Toxicology Reports. 2021;8:1419 [Crossref]
34- Barmoudeh Z, Fouani M, Moslemi Z, Azizi M, Doustimotlagh A, Bardania H. Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats. Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397(1):395 [Crossref]
35- Karami F, Jamaati H, Coleman-Fuller N, Zeini M, Hayes A, Gholami M, Salehirad M, Darabi M, Motaghinejad M. Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis. Pharmacol Rep. 2023;75(3):511 [Crossref]
36- Mostafa F, Galaly S, Mohamed H, Abdel-Moneim A, Abdul-Hamid M. Ameliorative effect of polydatin and polydatin-loaded chitosan nanoparticles against diabetes-induced pulmonary disorders in rats. Journal of Taibah University for Science. 2021;15(1):37 [Crossref]
37- Naghdi A, Goodarzi M, Karimi J, Hashemnia M, Khodadadi I. Effects of curcumin and metformin on oxidative stress and apoptosis in heart tissue of type 1 diabetic rats. J Cardiovasc Thorac Res. 2022;14(2):128 [Crossref]
38- Xie Q, Zhang X, Zhou Q, Xu Y, Sun L, Wen Q, Wang W, Chen Q. Antioxidant and anti-inflammatory properties of ginsenoside Rg1 for hyperglycemia in type 2 diabetes mellitus: systematic reviews and meta-analyses of animal studies. Front Pharmacol. 2023;14 [Crossref]